KR102709520B1 - 구강암을 치료하기 위한 약제를 제조하기 위한 진세노사이드 m1의 용도 - Google Patents

구강암을 치료하기 위한 약제를 제조하기 위한 진세노사이드 m1의 용도 Download PDF

Info

Publication number
KR102709520B1
KR102709520B1 KR1020207020053A KR20207020053A KR102709520B1 KR 102709520 B1 KR102709520 B1 KR 102709520B1 KR 1020207020053 A KR1020207020053 A KR 1020207020053A KR 20207020053 A KR20207020053 A KR 20207020053A KR 102709520 B1 KR102709520 B1 KR 102709520B1
Authority
KR
South Korea
Prior art keywords
ginsenoside
cells
oral cancer
vehicle
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207020053A
Other languages
English (en)
Korean (ko)
Other versions
KR20200143668A (ko
Inventor
시우-롱 리
쿠오-펑 후아
위-치에 리
Original Assignee
시우-롱 리
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시우-롱 리 filed Critical 시우-롱 리
Publication of KR20200143668A publication Critical patent/KR20200143668A/ko
Application granted granted Critical
Publication of KR102709520B1 publication Critical patent/KR102709520B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
KR1020207020053A 2018-04-17 2019-04-17 구강암을 치료하기 위한 약제를 제조하기 위한 진세노사이드 m1의 용도 Active KR102709520B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862658732P 2018-04-17 2018-04-17
US62/658,732 2018-04-17
PCT/CN2019/083058 WO2019201280A1 (en) 2018-04-17 2019-04-17 Use of ginsenoside m1 for manufacturing medicament for treating oral cancer

Publications (2)

Publication Number Publication Date
KR20200143668A KR20200143668A (ko) 2020-12-24
KR102709520B1 true KR102709520B1 (ko) 2024-09-25

Family

ID=68239265

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207020053A Active KR102709520B1 (ko) 2018-04-17 2019-04-17 구강암을 치료하기 위한 약제를 제조하기 위한 진세노사이드 m1의 용도

Country Status (9)

Country Link
US (1) US11524021B2 (https=)
EP (1) EP3668519B1 (https=)
JP (1) JP7307732B2 (https=)
KR (1) KR102709520B1 (https=)
CN (1) CN111615393B (https=)
DK (1) DK3668519T3 (https=)
ES (1) ES2889404T3 (https=)
TW (1) TWI820118B (https=)
WO (1) WO2019201280A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4153072A4 (en) * 2020-05-18 2024-05-22 ChemImage Corporation Systems and methods for detecting oral cancer using molecular chemical imaging
CN115300624A (zh) * 2022-07-08 2022-11-08 中国医学科学院药用植物研究所 人参皂苷联合pd-1阻断剂在制备抗头颈鳞癌药物中的应用
KR20250057225A (ko) 2023-10-19 2025-04-29 단국대학교 천안캠퍼스 산학협력단 차가버섯 추출물을 포함하는 구강암 예방 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106236761A (zh) * 2016-07-27 2016-12-21 陕西巨子生物技术有限公司 一种包含稀有人参皂苷c‑k的稀有人参皂苷组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59181217A (ja) * 1983-03-30 1984-10-15 Rooto Seiyaku Kk ダンマラン系化合物を含有する抗癌剤組成物
US20030185910A1 (en) * 2002-02-08 2003-10-02 Taik Koo Yun Cancer preventive composition comprising ginsenoside glycosides of red ginseng
WO2005034963A1 (en) * 2003-10-15 2005-04-21 Panagin Pharmaceuticals Inc. USE OF GINSENOSIDES Rh2 & Rg3, AND AGLYCON GINSENOSIDES FOR THE PREVENTION OF CANCER
CN103694297A (zh) * 2013-11-19 2014-04-02 大连杰信生物科技有限公司 提高人参皂苷m1与癸酰氯单酯化选择性的合成方法
EP3137089B1 (en) * 2014-05-02 2018-10-10 Sheau-Long Lee Use of ginsenoside m1 for treating lupus nephritis
EP3270929B1 (en) * 2015-03-17 2019-09-11 Lee, Sheau-Long Use of ginsenoside m1 for preventing or treating silicosis
KR101722547B1 (ko) * 2015-05-22 2017-04-04 한국과학기술원 파낙사디올류 진세노사이드 화합물을 포함하는 항암보조제

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106236761A (zh) * 2016-07-27 2016-12-21 陕西巨子生物技术有限公司 一种包含稀有人参皂苷c‑k的稀有人参皂苷组合物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jun-Jie Chen et al., Oncotarget 2013*
Lei Chen et al., Cell Death and Disease (2016) 7 (2016.08.11.)*

Also Published As

Publication number Publication date
ES2889404T3 (es) 2022-01-12
US20210023104A1 (en) 2021-01-28
US11524021B2 (en) 2022-12-13
CN111615393A (zh) 2020-09-01
WO2019201280A1 (en) 2019-10-24
JP7307732B2 (ja) 2023-07-12
EP3668519A4 (en) 2020-10-14
TW202002987A (zh) 2020-01-16
TWI820118B (zh) 2023-11-01
KR20200143668A (ko) 2020-12-24
EP3668519B1 (en) 2021-06-16
DK3668519T3 (da) 2021-08-23
CN111615393B (zh) 2023-10-10
JP2021517886A (ja) 2021-07-29
EP3668519A1 (en) 2020-06-24

Similar Documents

Publication Publication Date Title
KR102358632B1 (ko) 스트렙토니그린 및 항암제를 포함하는 대장암 예방 또는 치료용 약학적 조성물
KR102709520B1 (ko) 구강암을 치료하기 위한 약제를 제조하기 위한 진세노사이드 m1의 용도
KR101747775B1 (ko) 유포비아 인자 l1 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학적 조성물
KR20200002761A (ko) 지방줄기세포유래 엑소좀을 유효성분으로 포함하는 간 섬유증 예방 또는 치료용 조성물
Wu et al. Cordyceps sobolifera extract ameliorates lipopolysaccharide-induced renal dysfunction in the rat
EP3156058B1 (en) Anti-tumor pharmaceutical application of pentacyclic triterpene saponin compounds of szechuan melandium root
EP1549329B1 (en) Extract with anti-tumor and anti-poisonous activity
TWI606835B (zh) 基於靈芝多醣之組合物及治療癌症之方法
KR102774318B1 (ko) 개비자 추출물로부터 분리된 화합물을 유효성분으로 포함하는 폐암 예방 또는 치료용 조성물
Wu et al. Renoprotective activity of Ribes diacanthum pall (RDP) against inflammation in cisplatin-stimulated mice model and human renal tubular epithelial cells
WO2021023291A1 (zh) 原黄素在肺癌治疗中的应用
CN114984128A (zh) 薯蓣总皂苷及其衍生物在制备铁死亡抑制剂药物中的应用
CN115154457A (zh) 刺芒柄花素或其组合物在制备用于减轻蒽环类化疗药物心脏毒性的药物中的应用
CN110179915A (zh) 参麦注射液在制备逆转抗肿瘤药的耐药性药物中的应用
TW202116328A (zh) 人參皂苷m1用於治療癌症之用途
CN110237080A (zh) 低极性稀有人参皂苷混合物及其用途
CN110237081A (zh) 低极性稀有人参皂苷混合物δ(20-21)ppd/δ(20-22)ppd及其用途
CN107595859A (zh) 葫芦素c在制备广谱抗肿瘤药物中的应用
KR20240057564A (ko) 산마늘 추출물을 유효성분으로 함유하는 심근 손상의 개선, 예방 또는 치료용 조성물
KR20240056425A (ko) 냉이 추출물을 유효성분으로 함유하는 심근 손상의 개선, 예방 또는 치료용 조성물
TWI351965B (en) Composition for prophylaxis or treatment of urinar
KR20240056426A (ko) 고려엉겅퀴 추출물을 유효성분으로 함유하는 심근 손상의 개선, 예방 또는 치료용 조성물
KR20240056274A (ko) 삼백초 추출물을 유효성분으로 함유하는 심근 손상의 개선, 예방 또는 치료용 조성물
TWI406658B (zh) 使用異硫氰酸酯類來治療癌症之方法及用途
KR20120037925A (ko) 봉독 추출물을 유효성분으로 함유하는 혈관신생 관련 질환，폐암 또는 통증의 예방 및 치료용 조성물

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601